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Summary 
 
Health state profile data, such as those provided by the EQ-5D, are widely collected in 
clinical trials, population surveys and a growing range of other important health sector 
applications.  However, these profile data are difficult to summarise to give an overall view 
of the health of a given population that can be analysed for differences between groups or 
within groups over time.  A common way of short-cutting this problem is to transform 
profiles into a single number, or index, using sets of weights, often elicited from the general 
public in the form of values.  Are there any problems with this procedure?  In this paper we 
demonstrate the underlying effects of the use of value sets as a means of weighting profile 
data.  We show that any set of weights introduces an exogenous source of variance to health 
profile data.  These can distort findings about the significance of changes in health between 
groups or over time.  No set of weights is neutral its effect.  If a summary of patient reported 
outcomes is required, it may be better to use an instrument that yields this directly – such as 
the EQ VAS – along with the descriptive instrument.  If this is not possible, researchers 
should have a clear rationale for their choice of weights; and be aware that those weighs may 
exert a non-trivial effect on their analysis.  This paper focuses on the EQ-5D, but the 
arguments and their implications for statistical analysis are relevant to all health state 
descriptive systems. 
 
Keywords: Utility measurement, Health economics, Quality of Life, EQ-5D, Statistical 
inference 
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Introduction 
 
Health state data, derived from a variety of different measurement instruments, are widely 
collected in clinical trials, population surveys and a growing range of other important 
applications in the health sector.  Many of these instruments describe health states in terms of 
multiple attributes.  Moving beyond description to statistical analysis of health outcomes 
imposes requirements on the way that these data are presented – in particular, the need to 
construct from them a single indicator of the direction and magnitude of differences in health. 
 
An important example of an instrument for measuring health outcomes is the EQ-5D, 
developed by the EuroQol Group and intended for patient self-completion.1 The standard EQ-
5D self-report questionnaire comprises two parts: the EQ-5D self-classifier, which uses the 
EQ-5D descriptive system, and the EQ VAS, which records an overall rating of health from 0-
100 on a visual analogue scale.  Together, these give valuable information on the health states 
of individuals, groups of patients and populations. Common uses of the EQ-5D include 
comparisons of population health over time and between countries; monitoring the health of 
patient groups; and gauging the effectiveness and cost effectiveness of treatments. In the 
United Kingdom (UK), a number of other, more innovative uses of the EQ-5D have recently 
been proposed. From April 2009, patients’ self-reported health improvement on the EQ-5D 
will be used as a hospital performance indicator in the National Health Service (NHS), used 
to help patients choose which hospital to be referred to.2  The EQ-5D has also been advocated 
for use in measuring the productivity and performance of the NHS.3 
 
The self-classifier provides health state profile data that categorise the respondent’s health 
state according to the EQ-5D descriptive system, known as EQ-5D health states.  Unlike the 
EQ VAS data, these data are not single numbers, but a set of categorical variables recording 
the respondent’s health as one of three levels (essentially no, some or extreme problems) on 
each of five dimensions (mobility, self-care, usual activities, pain & discomfort and anxiety 
& depression).  Profiles therefore contain rich and detailed information on health states; 
unfortunately it is hard to summarise them concisely and even harder to analyse them for 
statistical inference purposes. 
 
Many studies have attempted to overcome this by converting the profile to a single index 
number, known as an EQ-5D index.  Such an index is easy to summarise and is easily 
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amenable to statistical inference techniques.  It is constructed by applying weights to each of 
the levels within each dimension and adding these together for particular health states.  
However, although this is in some cases a valid procedure, in many it is not.  The most 
obvious context in which an index is appropriate is cost-effectiveness analysis.4 However, 
there are many uses, both economic and non-economic, in which it is not so obvious. 
 
This paper examines the statistical properties of EQ-5D indexes, exposing the underlying 
processes and assumptions, and offers recommendations to users of the EQ-5D regarding the 
collection and analysis of data.  In particular, it examines the index in the context of statistical 
inference.  While our focus is on the EQ-5D, the issues we identify are relevant to any multi-
dimensional health state classification system which seeks to provide an overall summary 
measure of health. 
 
 
The uses of profile data 
 
EuroQol Group guidance on analysing and reporting EQ-5D data5 suggests that profile data 
should be reported as tables of frequencies and percentages of respondents having particular 
levels in particular dimensions.  In the Group’s publication on measuring self-reported 
population health6, descriptive data are presented as the percentage reporting each level in 
each dimension and summary statistics of EQ VAS ratings, with hypothesis testing restricted 
to the EQ VAS ratings.  The EuroQol website gives similar examples on the page ‘How to 
report EQ-5D results’.7 
 
The Group gives no guidance on how profile data might be analysed for statistical inference 
purposes, for example testing for significant differences in health status between patient 
groups or for significant changes within groups over time.  The most obvious descriptive 
technique to use for such categorical data would be contingency tables and tests of 
association such as χ2.  However, there are 243 possible EQ-5D health states, and although 
this is small relative to many other health status instruments, it is large enough to mean that 
there are severe limitations on how useful these techniques can be.  It is possible to examine 
each of the five dimensions separately for differences in the number of respondents in each 
level, requiring a 3x3 contingency table.  Analysing five such tables is quite feasible, but this 
does not provide an overall summary of the profile.  If a complete profile is looked at, there is 
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potentially a 243x243 contingency table, which is too cumbersome for any practical 
purposes.  Of course, in practice a large number of the potential states will not be found 
within real samples, but it is nevertheless unlikely to result in a small enough number to be 
analysable.  Furthermore, samples where there are many small or empty cells will require 
categories to be collapsed to make the data amenable to analysis, resulting in a loss of 
information.  
 
This problem is less acute if the EQ-5D is used in the way intended by the EuroQol Group, 
which is to use the complete EQ-5D self-report questionnaire.  The EQ VAS provides an 
overall summary of self-reported health as a single number between 0 and 100, which can 
readily be presented in the form of summary statistics or graphs and used for undertaking 
statistical inference.  However, in many applications the EQ-5D self-classifier is used as a 
stand alone measure, without the EQ VAS.  Examples include the use of the EQ-5D in 
official surveys such as, in the UK, the Health Survey for England (HSE)8 and surveys of 
NHS hospital inpatients.9 
 
Analysing EQ-5D profile data is also not problematic if they are to be used for cost-
effectiveness analysis – the context in which health economists are most familiar with the use 
of the EQ-5D.  The EQ-5D is one of the health outcome measures recommended by 
pharmaceutical reimbursement authorities in The Netherlands, New Zealand, Norway, Italy, 
Hungary, Poland and Portugal10.  The UK’s National Institute for Health and Clinical 
Excellence (NICE) states that “To allow comparisons across technologies, the Institute 
requires that health states should be measured in patients” and that “Currently, the most 
appropriate choice in the UK appears to be the EQ-5D.”11.  In its application in cost 
effectiveness analysis, an EQ-5D index is used as the quality of life element in the calculation 
of Quality Adjusted Life Years (QALYs).  The index is constructed by applying to each EQ-
5D health state a weight which represents the utility or value of that state, on a scale which 
has a maximum value of 1, representing full health, an anchor of 0, representing a state 
equivalent to being dead, and with states regarded as worse than being dead having a value 
lower than 0.  The use of the EQ-5D in economic evaluation is facilitated by the existence of 
EQ-5D value sets, often called ‘tariffs’, in many countries10.  These have been generated by 
asking members of the general public to consider health states described by the EQ-5D, 
which they may or may not have experienced, and to value those states using techniques such 
as a Visual Analogue Scale (VAS) and Time Trade-Off (TTO).  In the UK, the most widely 
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used weights are TTO values from a UK population study known as the MVH (Measuring 
and Valuing Health) study.12  More recently, a similar set of weights has been produced for 
the United States.13,14 
 
However, what of applications of the EQ-5D other than in economic evaluation?  The EQ-5D 
is now used in a wide range of applications in the health sector other than assessments of 
value for money – see Table 1. 
 
Table 1:  Applications of the EQ-5D in the health sector (excluding economic 
evaluation). 
Application Examples of use 
Comparing the health status of populations 
over time; comparing the health status of 
local populations with national population 
health, comparing population health 
internationally. 
Within the UK, the EQ-5D has been used in 
Health Survey for England (HSE) surveys for 
a number of years8 and in NHS surveys of 
inpatients.9 
Comparing the health of patient groups with 
that of comparable members of the general 
public 
Self-reported health on the EQ-5D has been 
compared with age/sex-adjusted population 
norms for the UK, to gauge the effects on 
quality of life associated with type 2 
diabetes.15 
Determining clinical priorities and managing 
demand for referral from primary to 
secondary services. 
New Zealand’s ‘points system’ for elective 
surgery utilised specially-designed scoring 
instruments to determine ‘clinical thresholds’ 
and ‘financial thresholds’16. The EQ-5D 
could potentially be used in this context. 
Routine use of the EQ-5D before and after 
surgery, as a means of monitoring, managing 
and reporting the performance of hospitals 
(or clinical teams) in improving health. 
From 2009, NHS hospitals will have a 
requirement to measure, using the EQ-5D as 
well as, in each case, a condition-specific 
instrument, patients’ self-reported health 
before and after surgery, for all patients 
undergoing four surgical procedures.2 
Monitoring variations and trends in the health 
of patients with long term conditions.  
Use of the EQ-5D in a daily patient diary for 
multiple sclerosis patients17.  
 
Each of these applications confronts the challenge noted above: given that EQ-5D profiles are 
not readily amenable to statistical analysis, how can overall health and changes in health be 
summarised and analysed? One solution is to use exactly the same procedure used in 
economic evaluation and apply a set of weights to create a single index.  In principle this 
could be any set of weights, but in practice the most common approach is to use the published 
value sets used in economic evaluation.  Are there any problems in using this solution? 
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EuroQol Group guidance to users of EQ-5D value sets18 warns against using value sets to 
produce a single index for statistical analysis of profiles that are meant to be purely 
descriptive.  This is because “there is no ‘neutral’ set of weights that can be used for this 
purpose” and “No set of weights is objective”.  It advises that “it may be better not to use an 
index, but to report the EQ-5D profiles themselves in some detail” and “where a single 
number is required to represent health … it may be more appropriate to focus on the EQ VAS 
data provided by the relevant patients or populations themselves … rather than applying 
social value sets to their EQ-5D profiles.” 18 p. 40 
 
However, the Group’s guidance is not always followed.  The report19 which informed the UK 
Department of Health’s introduction of routine use of the EQ-5D collected EQ-5D profiles 
and applied the MVH TTO value set to these to facilitate analysis.  Similarly, the EQ-5D data 
collected by the Health Survey for England appears to be summarised by application of the 
‘EuroQol tariff’.20 In both contexts, the data are explicitly meant to represent patient reported 
outcome measures, and there is no intention to interpret the numbers as values.  Indeed there 
are numerous published examples of EQ-5D profile data being converted into EQ Index 
values in non-economics applications, either instead of or in addition to analysis of the EQ 
VAS.  In most cases, no clear rationale for doing so is provided by the authors.  Recent 
examples include a study of the quality of life of diabetes patients21; the relationship between 
quality of life and alcohol dependency22; a longitudinal study of population health in 
Sweden23; and quality of life among stroke survivors24.  
 
The EuroQol Group’s guidance is mainly based on the disputed legitimacy of using value sets 
applicable to economic evaluation for other purposes.  The value sets that are used for 
economic evaluation have a clear theoretical rationale that underpins the form of the weights, 
the way that they are derived and their meaning.  This rationale may not extend to other uses 
and indeed may be entirely out of keeping with them.  The weights used in economic 
evaluation are explicitly regarded as ‘values’ or ‘utilities’, with a quite narrow definition 
attached to them.  There is a clear meaning attached to the values 1 and 0 and to values less 
than 0; it is desirable to use a recognised stated preference technique to obtain them; and 
there is a justification for the use of the general population as a source of weights.  The 
resulting weights should only be used in other applications if the same theoretical rationale 
also applies. 
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A contrasting view is that the weights really do not matter; most of the variation in an EQ-5D 
index is due to differences between respondents rather than the weighting structure and it is 
unnecessary to use social preference-based values rather than a simple set of weights.  This 
was the argument of Prieto and Sacristán (2004), who compared for a large data set an index 
weighted using the MVH values with one using equal weights for both levels and 
dimensions, finding mean values that differed by what they regarded as a negligible 
amount.25 
 
But there is another relevant question about the use of weights: what are the statistical 
properties of the resulting index?  One issue is that although the weights are treated as fixed 
coefficients, they are in fact themselves estimates derived from a sample, and therefore have 
a sample distribution which ought to be taken into account in any statistical inference.  Since 
statistical testing of the index tests both the profile data and the weights, we speculate that 
some account ought to be taken of the variability of the weights.  Unfortunately, as this will 
be derived from a completely different sample, it is not obvious how this might be 
undertaken.  This is a complex question which is not dealt with in this paper.  We look at 
another issue, which applies whether or not weights are fixed - how adding weights to profile 
data affects statistical inferences made about the resulting index. 
 
A decomposition of the EQ-5D index 
 
It is important to remember that we are interested in the EQ-5D index as a summary of a set 
of EQ-5D profile data, referring to a particular patient or population group.  Any EQ-5D 
index, whatever the source and structure of its weights, is made up of not only the profile data 
under analysis but also another data set made up of the weights that are used to convert the 
profile data into a single number.  It is useful to analyse the role of each of these data sets in 
determining the numbers that are calculated for the index, and we will therefore decompose 
the index into its separate constituents. 
 
The usual procedure for calculating an EQ-5D index is first to convert the profile data into a 
set of binary variables.  The most important of these binary variables are derived from the 
categorical variables that describe the levels of each dimension of the EQ-5D.  As described, 
each dimension of the EQ-5D has three levels: ‘no problems’; ‘some problems’; and ‘extreme 
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problems’.  Two binary variables can therefore be used for each dimension: the presence or 
absence of the ‘some problems’ level, which we will refer to as Level 2; and the presence or 
absence of the ‘extreme problems’ level, which we will refer to as Level 3.  The absence of 
both of these indicates ‘no problems’, or Level 1.  As there are five dimensions, there are 
5x2=10 binary variables of this kind. 
 
There may also be other binary variables that represent interaction effects between 
dimensions and levels.  Two widely used variables of this kind are one that records the 
presence of any Level 2 or Level 3 state, referred to as a ‘constant’ because of its derivation 
from a regression equation, and another that records the presence of any Level 3 health state, 
referred to as ‘N3’, a term used in the MVH study.12 
 
Weighting the profile data to create an index therefore in practice means attaching weights to 
these binary variables.  In what follows, it is assumed that for each binary variable, 0 
represents absence of a level within a dimension or an interaction and 1 represents its 
presence. 
 
Let 
 
Hj = Index score4 for individual j 
bi =  Binary variables representing levels within dimensions 
wi = Index weights for binary variable bi 
 
Then 
 
∑ == ki ijij bwH 1  where ⎩⎨
⎧
=
=
nj
ki
…
…
,1
,,1
 [1] 
 
In this formulation, no constraints are placed on the numeric values given to the index 
weights or the index scores because, as will be shown, this has no impact on inference issues.  
Nevertheless, it does raise an important issue, because for most applications using health 
status information we will be interested in absolute values of the index, of differences in the 
                                                 
4  For clarity, we describe the index here as an indicator of subtractions from full health.  It would be necessary 
to subtract this value from 1 to give an index where higher values mean better health. 
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index between different groups and of changes within groups over time.  In clinical studies, 
for example, knowing the absolute value of the effect size is as important as knowing whether 
or not it is significantly different from zero.  For that reason, it is not enough simply to have 
weights that describe the relative importance of different levels and dimensions.  A key point 
here is the fact that the concept of overall health status has no natural units in which it can be 
measured, although value sets do in effect have units of measurement, derived from the way 
that they are constructed and the way that they are used. 
 
In what follows we will examine the problems that arise in statistical testing of the mean of 
this index, in particular comparing differences in its value for two population or patient 
groups.  However, it should be noted that the same problems will arise in calculating and 
making inferences about other statistics, for example correlation coefficients, and therefore 
tests of association as well as tests of difference. 
 
To tests for differences in the value of the index requires us to know its mean and variance.  
Since the individual values of the index are calculated from the values of the binary variables 
and the weights, it follows that the mean and variance of the index must also be a function of 
these two elements.  In fact, the mean and variance of H turn out to have fairly obvious 
relationships with the corresponding statistics for the binary variables. 
 
Mean of the index 
 
Let 
H =Mean value of Hj 
ib = Mean value of bi 
 
It can be shown that 
 
∑ == ki iibwH 1  [2] 
 
The mean value of Hj is therefore a weighted sum of the means of the binary variables, using 
the same weights and weighting structure as for the individual values of Hj. 
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What does this mean value tell us?  If the binary variables are indicators of the presence or 
absence of a particular level in a particular dimension, then their mean values are simply the 
proportions of the sample with that level in that dimension.  The mean value of Hj is in effect 
a summary of these proportions over all levels and dimensions, weighting the relative 
importance attached to them.  This seems a reasonable thing to do, if the weights are 
appropriate to the task.  However, it is important to recognise that the mean value is 
determined both by the data that directly describe the sample – the profile data - and by data 
that are generated externally to the sample – the weights.  It is equally accurate to describe 
the mean value of the index as a set of constant values (the wi) that are weighted by the 
relative proportions observed in a particular sample or population. 
 
The addition of terms such as N3 and the constant complicates this slightly.  It is arguably 
justified to include these if the index is regarded as measuring a concept of health in which 
the simple binary variable weightings do not fully capture the relative importance of different 
levels and dimensions.  However, users of the index who mean it merely to be a descriptive 
summary ought to be aware of the weight structure that they are building in, and its origins.  
In the case of most of the value sets widely used, the interaction terms are included solely to 
optimise the statistical properties of an equation describing an entirely different type of data – 
valuations of described health states - taken from a completely separate sample or population. 
 
Variance of the index 
 
Let 
2
Hσ = variance of jH  
2
iσ  = variance of ib  
liσ = covariance of ib  and lb , li <  
 
Again, it can be shown that 
 
∑ ∑= <+= ki il liiliiH www1 222 2 σσσ  [3] 
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The variance of Hj is a weighted sum of both the variance of each binary indicator and the 
covariance between each binary indicator, again using the index weights.  It cannot be 
expressed as a function simply of the variances. 
 
The interpretation of the term in [3] that includes the variances of the binary variables is quite 
straightforward.  The variance of a binary variable is the proportion of ones in the data 
multiplied by the proportion of zeroes; since the proportion of ones is the mean, the variance 
is:  
 
( )bbi −= 12σ  
 
The covariance term is more complicated.  The covariance of two binary variables is the 
proportion of cases in the data where both variables take the value one, which is the mean of 
their products, minus the product of the proportion of each that takes the value one, which is 
the product of their means.  The covariance is therefore: 
 
ililli bbbb −=σ  
 
This is complicated by the fact that the ib  include indicators representing different levels 
within a single dimension.  Where this is the case, the first term in the covariance definition 
will be zero and the covariance must therefore be negative. 
 
The covariance term introduces interactions not only between the different levels and 
dimensions of the data but also between the weights – the li ww terms.  In general, the 
variance for jH  is a complex function not only of variance and covariance terms but also of 
the weights. Expressed in terms of means of the binary variables, the variance in [3] 
becomes: 
 
( )( ) ( )∑ ∑= < −+−= ki il ilililiH bbbbwwbbw1 22 21σ  [4] 
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Testing for differences between means 
 
For simplicity, let us assume that we are conducting a test of the differences in H between 
two groups X and Y with the same sample size, n.  The means for populations X and Y are: 
 
∑ == nj XjX HnH 11  
 
∑ == nj YjY HnH 11  
 
The difference in means can be shown to be 
 
( )∑ = −=− ki YiXiiYX bbwHH 1  [5] 
 
The difference in means is therefore a linear weighted sum of the difference in means of the 
binary variables, in other words of the difference between the proportions of the two samples 
having each level in each dimension.  This definition and those of the individual index 
numbers and their mean value are symmetrical. 
 
The variance of this difference is: 
 
( ) ( ) ( )( )∑∑ <= +++=− il YliXliilki YiXiiYX wwwnHHVar σσσσ 21 1 222  [6] 
 
which can also be expressed as 
 
( ) ( )( ) ( )( )( )( ) ( )( )⎟⎟⎠
⎞
⎜⎜⎝
⎛
−+−+
−+−=− ∑
∑
<
=
il YlYlYiYlXlXlXiXlil
k
i YYXXi
YX
bbbbbbbbww
bbbbw
nHHVar 2
111 1
2
 [7] 
 
The variance of the difference in means is again a non-linear weighted function of the 
variances and covariances.  This definition and that of the variance are symmetrical. 
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The appropriate test statistic for a normally distributed variable with unknown population 
standard deviation is the t statistic: 
 
( )YX
YX
HH
HHt −
−=
var
 [8] 
 
If we substitute expressions [5] and [6] into [8], it is apparent that the numerator of [8] is 
linear in weights, but the denominator is non-linear and complex.  The weights do not ‘cancel 
out’ and they are therefore an important determinant of the value of the t statistic.  The 
consequence is that the weights chosen may determine statistical significance; different sets 
of weights may give different conclusions about whether or not two groups are significantly 
different to each other.  As suggested earlier, the same problem would occur if other 
statistical procedures are carried out, such as tests of association using correlation 
coefficients. 
 
This problem is however restricted to weights that differ in their relative values, not their 
absolute values.  To demonstrate this, suppose that we have two sets of weights that give the 
same relative weights to different levels and dimensions – for example, the weight for Level 
2 pain is twice as big as that of Level 3 pain, the weight for Level 2 anxiety is twice that of 
Level 2 self-care, and so on for all possible dimensions and levels.  However one has absolute 
values twice as big as the other.  This can be represented as a scalar λ, in this case 2, applied 
to each wi.  Examining equations [2] and [5], it is apparent that this will result in H  
becoming λ H  and ( YX HH − ) becoming λ( YX HH − ).  Similarly, from equations [3] and 
[6], 2Hσ  will become λ2 2Hσ  and ( )YX HHVar −  will become λ2 ( )YX HHVar − .  λ will 
therefore cancel out in equation [8], so that the value of t is not dependent on the absolute 
values of the weights. 
 
A simulated empirical example 
 
In order to demonstrate the conclusions of our analysis, a simple simulation was performed.  
The procedure was as follows: 
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1 Generate a random sample of 100 from the 243 possible EQ-5D health states, without 
replication (Group 1). 
2 Generate an identical set of data, except for 5 of the health states chosen at random, 
which are changed to give a one-level improvement in one dimension of the EQ-5D 
(Group 2). 
3 Apply different sets of weights to the resulting data.  Each set of weights is applied 
equally to the two groups to generate an index score for each. 
4 Calculate paired comparison t tests of the differences in the index scores of Group 1 
and Group 2 for each set of weights. 
 
Because of their widespread use in the UK and elsewhere, the MVH weights were chosen as 
one of the comparators.  It is possible to compare these directly with two other published sets 
of weights, based on data from the Netherlands26 and Spain27.  There are several other TTO-
based sets available, but these have a slightly different structure (for example, no N3 terms 
for weights from Denmark, Japan, the USA and Zimbabwe)10.  Our conclusions apply equally 
to the use of these sets of weights, and to others based on other valuation methods, but to 
make a clean comparison we focus on the three sets that are identically structured and 
derived. 
 
To explore in more detail how different relative weights affect inference, we also examined 
nine artificial sets of weights.  Four of these had equal weights for each of the dimensions, 
but different weights for the levels within each of them.  As explained, the binary variables 
represent the presence or absence of Level 2 and Level 3 responses within a dimension.  A 
higher weight was given to Level 3 by multiplying the Level 2 by a constant.  Four different 
multipliers were used; 2, 3, 4 and 10.  The other five sets had different weights for each level 
in different dimensions.  This was achieved by adding a constant absolute increment to both 
weights within a dimension, so that, for example, 0.005 is added to the Level 2 and Level 3 
weights for mobility to obtain those for self-care, 0.01 is added to obtain those for usual 
activities, and 0.015 and 0.02 to obtain those for pain/discomfort and anxiety/depression 
respectively.  Using the same increment, two different multipliers, 4 and 5, were used for the 
relative weights for levels.  In each case, the resulting weights were applied first to the 
dimensions in the order in which they appear in the EQ-5D questionnaire and then to the 
dimensions in a random order.  The final set of weights was for a higher increment, 0.01. 
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These numbers used as multipliers and increments were chosen to produce mean values 
comparable to those arising from the MVH weights.  That is an arbitrary criterion and it is 
therefore not meaningful to compare the actual mean values.  However, as explained, the 
absolute values do not affect the results in terms of t and p values.  So, to prevent any 
misleading comparisons, Table 2 reports the p values for a two-tailed paired comparison test 
for each set of weights, but does not report any of the means and standard deviations. 
 
Table 2:  Significance tests of differences between simulated samples of health states 
according to different sets of weights. 
 
Description p value,  two tailed t-test 
UK weights 0.041 
Netherlands weights 0.067 
Spanish weights 0.029 
Equal weights dimensions; Level3 = 2*Level2 0.025 
Equal weights dimensions; Level3 = 3*Level2 0.033 
Equal weights dimensions; Level3 = 4*Level2 0.052 
Equal weights dimensions; Level3 = 10*Level2 0.160 
Unequal weights dimensions; Increment = 0.005, Level3 = 5*Level2 0.095 
Unequal weights dimensions; Increment = 0.005, Level3 = 5*Level2
Same weights as previous, but moved between dimensions 0.054 
Unequal weights dimensions; Increment = 0.005, Level3 = 4*Level2 0.065 
Unequal weights dimensions; Increment = 0.005, Level3 = 4*Level2
Same weights as previous, but moved between dimensions 0.041 
Unequal weights dimensions; Increment = 0.01, Level3 = 5*Level2 0.122 
 
The table show that when using the UK and Spanish weights the t test detected a significant 
difference in the means at the 5% level, although with quite different p values.  Using the 
Netherlands weights, however, suggests that the means are not significantly different at the 
5% level.  Where weights were assumed equal for each dimension, the p value depended on 
the relative size of the weights for level 2 and level 3.  The greater the difference in the 
weights between levels, the higher the p value.  Relative weightings of 3 and below generated 
a significant difference at the 5% level, those 4 and above an insignificant difference. 
 
Where weights were unequal between dimensions, the same result held and in addition the 
greater the difference in weights between dimensions the lower the p value.  The interaction 
between the weighting structure and the data was also an important determinant of the p 
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value.  If the weights for different dimensions were switched, the p value changed, and in one 
of the examples this resulted in a change from significance to non-significance. 
 
We therefore find that our theoretical results are both correct and of some practical 
importance.  The t-test is sensitive to weights, and therefore a test of differences in the means 
of the health index between groups tests not only differences that arise from the groups but 
also differences between the weights.  Another way to view this is that there is, for a given 
sample size, a value of t for a given set of weights that is simply modified by the data.  There 
must be some doubt, therefore, about whether the levels of significance that are implied by 
the test are in fact appropriate for this kind of data. 
 
 
Conclusions 
 
An alarming conclusion from our empirical analysis is that clinical trials carried out in the 
UK and the Netherlands that produce exactly the same EQ-5D data might lead researchers to 
make completely different statistically-based conclusions about the effectiveness of the 
intervention being studied.  Many countries do not have weights of their own and therefore 
have to use foreign weights; whether or not an intervention is seen as effective in such a 
country might depend on which other country’s weights it chooses. 
 
The problem of using an index created from weighted profile data is that any statistical 
analysis is affected by information that is not inherent to the sample data; variations in the 
index reflect variations not only in the sample but also in the weights.  Statistical tests of 
significance also introduce complexities into the weighting system via the variance, in 
particular interactions between weights, levels and dimensions that are not in the original 
weighting structure.  This may have the uncomfortable implication that conventional 
significance tests are inappropriate and give misleading levels of significance.  This is most 
obviously an issue where the index is intended as a convenient summary of descriptive data, 
but the problem will also apply where it is intended as a value or utility, unless the underlying 
weights can be regarded as fixed.  If they are regarded as variable, this casts some doubt on 
the results from very many published cost-effectiveness studies. 
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The main conclusion from this analysis is to reinforce the recommendation that applying sets 
of weights to profile data in order to produce an index should not be used as a short-cut 
method of summarising profile data and of facilitating statistical inference from such data.  It 
is only justifiable to create and make inferences from an index where the weights have 
specifically been created to produce a meaningful value relevant to the purpose for which the 
data are being used, which will represent some concept of what health is.  This need not be 
‘value’ in the economic sense; it could for example represent a clinical view of the severity or 
burden of illness.  For inference purposes, all that is then needed is weights that represent the 
relative importance of different dimensions and levels of health, although producing numbers 
that are meaningful in an absolute sense requires much more.  If the weights used in an index 
have simply been imported and are not relevant to the purpose for which they are used, using 
that index is at best misguided and at worst misleading. 
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